isocarboxazid has been researched along with Inborn Errors of Metabolism in 2 studies
Isocarboxazid: An MAO inhibitor that is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in the treatment of panic disorder and the phobic disorders. (From AMA, Drug Evaluations Annual, 1994, p311)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Watts, RW | 1 |
| Chalmers, RA | 1 |
| Gibbs, DA | 1 |
| Lawson, AM | 1 |
| Purkiss, P | 1 |
| Spellacy, E | 1 |
| Bourke, E | 1 |
| Frindt, G | 1 |
| Flynn, P | 1 |
| Schreiner, GE | 1 |
2 other studies available for isocarboxazid and Inborn Errors of Metabolism
| Article | Year |
|---|---|
Studies on some possible biochemical treatments of primary hyperoxaluria.
Topics: Adolescent; Adult; Animals; Child; Cholestyramine Resin; Female; Haplorhini; Humans; Isocarboxazid; | 1979 |
Primary hyperoxaluria with normal alpha-ketoglutarate: glyoxylate carboligase activity. Treatment with isocarboxazid.
Topics: Allopurinol; Child; Female; Glycolates; Glyoxylates; Humans; Isocarboxazid; Ketoglutaric Acids; Kidn | 1972 |